PMDA Sakigake Designation
EAP180 days
Regulatory Framework
PMDA Strategy of SAKIGAKE
Eligibility Criteria
First-in-world development in Japan for severe diseases, significant efficacy expected
Available Drugs (0)
No drugs linked to this program.
PMDA Strategy of SAKIGAKE
First-in-world development in Japan for severe diseases, significant efficacy expected
No drugs linked to this program.